Gosavi Suchitra Rajesh, Torkadi Amruta Appasaheb
Department of Oral Pathology and Microbiology, Government Dental College and Hospital, Nagpur, Maharashtra, India.
J Oral Maxillofac Pathol. 2020 Jan-Apr;24(1):46-51. doi: 10.4103/jomfp.JOMFP_317_19. Epub 2020 May 8.
Early detection of oral squamous cell carcinoma (OSCC) and oral submucous fibrosis (OSMF) transforming into malignancy can drastically improve the treatment outcomes and prognosis. Carcinoma development is an intricate complex mechanism and the multifactorial causation makes it more difficult to find specific prognostic and therapeutic biomarkers. Thus, the development of newer diagnostic and predictive approaches that are less invasive, economical and amenable to repeated sampling is imperative. Serum C-reactive protein (CRP) serves a useful marker for prognosis and monitoring of oral potentially malignant disorders (OPMDs) including OSMF as well as OSCC. Secreted by hepatocyte as an acute inflammatory marker, various studies have shown association between serum CRP and presence of OPMDs, as well as with presence and prognosis of OSCC.
The aim of this study was to measure and compare serum CRP levels in patients with OSMF and OSCC as compared to healthy individuals and to establish baseline data for serum CRP levels in patients with OSMF and OSCC.
Cross-sectional observational prospective study.
The study includes 150 individuals, with 50 healthy, 50 OSMF and 50 OSCC individuals. Spinreact CRP-turbilatex Kit (SPINREACT) and Prietest-EXP semi-automatic biochemical analyzer were used for quantitative determination of serum CRP.
Data were analyzed by SPSS 16 (Statistical Package for the Social Sciences) software.
The mean value of serum CRP in Group I was 2.20 mg/L with standard deviation of 1.74; in Group II, it was 5.40 mg/L with standard deviation of 4.79 mg/L and in Group III, it was 12.17 mg/L with standard deviation of 11.38.
Serum CRP levels in patients with OSMF were raised, but not statistically significant as compared to the control group. Values of serum CRP were significantly higher in patients with OSCC as compared to the control group, and it was statistically significant; these values also showed positive association with primary tumor size.
早期发现口腔鳞状细胞癌(OSCC)以及口腔黏膜下纤维化(OSMF)向恶性转化能够显著改善治疗效果和预后。癌症发展是一个复杂的机制,多因素致病使得寻找特定的预后和治疗生物标志物变得更加困难。因此,开发更新的诊断和预测方法势在必行,这些方法应具有侵入性小、经济且适合重复采样的特点。血清C反应蛋白(CRP)是一种用于口腔潜在恶性疾病(OPMDs)(包括OSMF以及OSCC)的预后评估和监测的有用标志物。CRP作为一种急性炎症标志物由肝细胞分泌,多项研究表明血清CRP与OPMDs的存在以及OSCC的存在和预后之间存在关联。
本研究的目的是测量并比较OSMF和OSCC患者与健康个体的血清CRP水平,并建立OSMF和OSCC患者血清CRP水平的基线数据。
横断面观察性前瞻性研究。
该研究纳入150名个体,其中50名健康个体、50名OSMF患者和50名OSCC患者。使用Spinreact CRP-turbilatex试剂盒(SPINREACT)和Prietest-EXP半自动生化分析仪对血清CRP进行定量测定。
数据采用SPSS 16(社会科学统计软件包)软件进行分析。
第一组血清CRP的平均值为2.20mg/L,标准差为1.74;第二组为5.40mg/L,标准差为4.79mg/L;第三组为12.17mg/L,标准差为11.38。
OSMF患者的血清CRP水平有所升高,但与对照组相比无统计学意义。与对照组相比,OSCC患者的血清CRP值显著更高,且具有统计学意义;这些值还与原发肿瘤大小呈正相关。